View Older Stories View More Recent Stories
-
RBC Capital Downgrades Campus Crest Communities (CCG) to Underperform
-
Concordia Healthcare Announces Fourth Quarter and Fiscal 2014 Results
-
Building a Liqudity Safety Net for Public Companies and Investment Products in Canada
-
Building a Liquidity Safety Net for Public Companies and Investment Products in Canada
-
TeraGo Inc. to Acquire RackForce Networks Inc.
-
GoDaddy Sees IPO Price of $17 - $19/Share; Values Company ~3B
-
Esperion Therapeutics (ESPR) Prices 1.75M Common Offering at $100/Share
-
Candente Gold Appoints Acting Chief Financial Officer and Advances Testing of Tailings With Minera Arcu
-
Candente Copper's Names Acting CFO and Oversubscription of Financing
-
Esperion Therapeutics Prices Public Offering of Common Stock
-
Arlington Asset Investment Corp. Announces Closing of Senior Notes Offering
-
Tekmira Pharma (TKMR) to Offer 6M Common Shares
-
Tekmira Announces Proposed Public Offering of Common Shares
-
Tekmira Announces Proposed Public Offering of Common Shares
-
TalkLocal Founder Manpreet Singh To Speak At RBC Capital Markets Event Tonight in New York
-
Kraft Foods Group (KRFT) Falls on Large Kraft Macaroni & Cheese Recall
-
Notable Analyst Rating Changes 3/18: (CLMT) (P) (NTDOY) Upgraded; (MAC) (NAV) (STJ) Downgraded
-
Notable Mergers and Acquisitions 3/18: (TEVA)/(RXDX) (MSCC)/(VTSS) (MGLN)
-
Epizyme (EPZM) 6M Offering Prices at $20.75/Share
-
TherapeuticsMD Appoints Biopharmaceutical Senior Executives Angus C. Russell and J. Martin Carroll as Independent Directors
-
Microsemi (MSCC) to Acquire Vitesse Semiconductor (VTSS) for $5.28/Share
-
Microsemi Corporation to Acquire Vitesse Semiconductor Corporation
-
RBC Capital Upgrades Calumet Specialty Products Partners (CLMT) to Outperform
-
Epizyme Announces Pricing of Public Offering of Common Stock
-
Esperion Therapeutics (ESPR) to Offer $150M In Common Stock
-
Esperion Therapeutics Announces Proposed Public Offering of Common Stock
-
Zayo Group Holdings, Inc. Completes Follow-on Public Offering of Common Stock
-
Eagle Pharmaceuticals (EGRX) 1.3M Offering Priced at $42/Share
-
Valeant Pharma (VRX) Prices 7.29M Common Offering at $199/Share
-
Eagle Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Valeant Pharmaceuticals Prices Offering Of $1.45 Billion Of Common Shares
-
Bryan Cummings Joins D.A. Davidson & Co. Investment Banking Team
-
Micron (MU) Est., PT Cut at RBC Capital
-
World Wealth Report Wins Best PR Program Award at Family Wealth Report Awards 2015
-
World Wealth Report Wins Best PR Program Award at Family Wealth Report Awards 2015
-
Eagle Pharmaceuticals (EGRX) Commences $50M Stock Offering
-
Epizyme (EPZM) to Offer 4.75M Common Shares
-
Epizyme Announces Proposed Public Offering of Common Stock
-
Eagle Pharmaceuticals Announces Commencement of Public Offering of Common Stock
-
Notable Mergers and Acquisitions 3/16: (VRX)/(SLXP) (LTM) (KKR)/(GE) (BX) (SHLM)
-
Leonard Green, TPG to Acquire Life Time Fitness (LTM) in $4B+ Deal
-
RBC recognized with five top honours at the Family Wealth Report Awards
-
Life Time Fitness Enters Into Definitive Agreement to Be Acquired by Affiliates of Leonard Green & Partners and TPG
-
Encana Completes C$1.25 Billion Bought Deal Offering
-
RBC Comments on Amgen (AMGN) Repatha Data
-
Main Street Closes Public Offering of Common Stock
-
Notable Analyst Rating Changes 3/13: (EBAY) (INTC) (MBLY) Upgraded; (HST) (QIWI) (LL) Downgraded
-
RBC Capital Starts Enable Midstream Partners (ENBL) at Sector Perform
-
RBC Capital Downgrades Royal Dutch Shell (RDS-A) to Sector Perform
-
RBC Capital Starts Regal Beloit (RBC) at Sector Perform


